CASI Pharmaceuticals, Inc. (CASI): Price and Financial Metrics

CASI POWR Grades

• Sentiment is the dimension where CASI ranks best; there it ranks ahead of 92.2% of US stocks.
• CASI's strongest trending metric is Stability; it's been moving up over the last 179 days.
• CASI's current lowest rank is in the Quality metric (where it is better than 1.68% of US stocks).

CASI Stock Summary

• The ratio of debt to operating expenses for CASI Pharmaceuticals Inc is higher than it is for about merely 0.5% of US stocks.
• With a year-over-year growth in debt of -100%, CASI Pharmaceuticals Inc's debt growth rate surpasses only 0% of about US stocks.
• As for revenue growth, note that CASI's revenue has grown 99.25% over the past 12 months; that beats the revenue growth of 91.8% of US companies in our set.
• If you're looking for stocks that are quantitatively similar to CASI Pharmaceuticals Inc, a group of peers worth examining would be QTRX, IMMR, NVVE, TRIP, and STRM.
• CASI's SEC filings can be seen here. And to visit CASI Pharmaceuticals Inc's official web site, go to www.casipharmaceuticals.com.

CASI Valuation Summary

• CASI's price/sales ratio is 10.2; this is 10.13% lower than that of the median Healthcare stock.
• CASI's price/sales ratio has moved down 40 over the prior 243 months.
• CASI's price/earnings ratio has moved down 0.6 over the prior 243 months.

Below are key valuation metrics over time for CASI.

CASI Growth Metrics

Its 3 year net cashflow from operations growth rate is now at -394.4%.
• The 3 year cash and equivalents growth rate now stands at 615.22%.
• Its year over year revenue growth rate is now at 131.8%.

Over the past 33 months, CASI's revenue has gone up $25,832,000.

The table below shows CASI's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-09-30	25.832	-27.233	-45.252
2021-06-30	21.962	-30.203	-51.981
2021-03-31	17.471	-29.253	-53.729
2020-12-31	15.141	-25.886	-48.287
2020-09-30	11.663	-22.672	-46.987
2020-06-30	10.208	-20.59041	-39.68

CASI's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• CASI has a Quality Grade of F, ranking ahead of 3.6% of graded US stocks.
• CASI's asset turnover comes in at 0.158 -- ranking 218th of 682 Pharmaceutical Products stocks.
• DRNA, RARE, and ALNY are the stocks whose asset turnover ratios are most correlated with CASI.

The table below shows CASI's key quality metrics over time.